Neothetics, Inc. (NASDAQ:NEOT) released its quarterly earnings results on Thursday. The biotechnology company reported ($0.20) earnings per share for the quarter, meeting the consensus estimate of ($0.20), Bloomberg Earnings reports.

Neothetics (NASDAQ NEOT) traded up 0.80% during mid-day trading on Friday, reaching $0.38. 329,331 shares of the company traded hands. The company’s 50 day moving average price is $0.62 and its 200 day moving average price is $1.51. The firm’s market capitalization is $5.26 million. Neothetics has a 12-month low of $0.30 and a 12-month high of $2.63.

TRADEMARK VIOLATION NOTICE: This story was reported by Daily Political and is the sole property of of Daily Political. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at

Separately, ValuEngine cut shares of Neothetics from a “sell” rating to a “strong sell” rating in a report on Tuesday, June 27th.

Neothetics Company Profile

Neothetics, Inc is a clinical-stage specialty pharmaceutical company, which develops therapeutics. The Company focuses on localized fat reduction and body contouring. It focuses on the development of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.

Earnings History for Neothetics (NASDAQ:NEOT)

Receive News & Ratings for Neothetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neothetics Inc. and related companies with's FREE daily email newsletter.